Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results
source: pixabay.com

Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results

As seen in PR Newswire, researchers at the biopharmaceutical company OxThera AB have spent 52 weeks studying 25 patients with primary hyperoxaluria (PH), a rare disease that progressively damages the…

Continue Reading Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results